|
|
||||||||
1Department of Medicine, Veterans Affairs Hospital, Hines, Illinois, and Loyola University Stritch School of Medicine, Maywood; and 2Hektoen Institute for Medical Research, Chicago, Illinois
Submitted 23 April 2003 ; accepted in final form 26 January 2005
Recent evidence suggests that the intrarenal renin-angiotensin system (RAS) may play an important role in the development of glomerular changes associated with diabetic nephropathy. In this study, the glomerular RAS was examined in male Sprague-Dawley rats made diabetic with streptozotocin (STZ), and the findings compared with those obtained in control nondiabetic rats. In diabetic rat glomerular extracts, angiotensinogen and angiotensin II (ANG II) levels were increased significantly by 2.2- and 1.9-fold, respectively, compared with nondiabetic controls. No significant differences in ANG I and angiotensin-converting enzyme (ACE) levels were observed between these groups. The HPLC analysis of the glomerular extracts demonstrated that exogenous ANG I was converted into various ANG peptides including ANG II, ANG(19), and ANG(17). A significant increase in formation of ANG II from exogenous ANG I was observed in STZ rats compared with control rats. Preincubation of glomerular extracts with captopril resulted in a 2030% decrease in ANG II conversion from exogenous ANG I in diabetic and control rats. The possible role of ANG(19) in formation of ANG II was examined by HPLC. Exogenous ANG(19) in glomerular extracts was converted into ANG II, this conversion being significantly higher in STZ rats than in control rats. These findings provide new information that ANG(19) is produced in rat glomerular extracts, can be converted to ANG II, and that this conversion is also stimulated in diabetic rat glomeruli. Thus this study demonstrates that in diabetic rats, glomerular ANG II levels are increased due to an increase in angiotensinogen and an increase in the formation of ANG II.
diabetes; angiotensin peptides; angiotensin(19)
This article has been cited by other articles:
![]() |
J. C. Q. Velez, K. J. Ryan, C. E. Harbeson, A. M. Bland, M. N. Budisavljevic, J. M. Arthur, W. R. Fitzgibbon, J. R. Raymond, and M. G. Janech Angiotensin I Is Largely Converted to Angiotensin (1-7) and Angiotensin (2-10) by Isolated Rat Glomeruli Hypertension, May 1, 2009; 53(5): 790 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Shi, D. Nikolic, S. Liu, H. Lu, and S. Wang Activation of renal renin-angiotensin system in upstream stimulatory factor 2 transgenic mice Am J Physiol Renal Physiol, February 1, 2009; 296(2): F257 - F265. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Brands and H. Labazi Role of Glomerular Filtration Rate in Controlling Blood Pressure Early in Diabetes Hypertension, August 1, 2008; 52(2): 188 - 194. [Full Text] [PDF] |
||||
![]() |
M. C. Chappell Emerging Evidence for a Functional Angiotensin-Converting Enzyme 2-Angiotensin-(1-7)-Mas Receptor Axis: More Than Regulation of Blood Pressure? Hypertension, October 1, 2007; 50(4): 596 - 599. [Full Text] [PDF] |
||||
![]() |
J. C. Q. Velez, A. M. Bland, J. M. Arthur, J. R. Raymond, and M. G. Janech Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes Am J Physiol Renal Physiol, July 1, 2007; 293(1): F398 - F407. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |